These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9551214)

  • 1. New anticancer agents.
    Weiss GR; Burris HA; Eckhardt SG; Rodriguez GI; Sharma S; Valley A
    Cancer Chemother Biol Response Modif; 1997; 17():178-94. PubMed ID: 9551214
    [No Abstract]   [Full Text] [Related]  

  • 2. New anticancer agents.
    Britten C; Hammond L; Hidalgo M; Rothenberg ML; Sharma A; Sharma S; Siu L; Villalona-Calero M; Weiss GR
    Cancer Chemother Biol Response Modif; 1999; 18():178-209. PubMed ID: 10800483
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the mechanism of antitumor activity of 5-FU and its derivatives--relationship between the inhibition of tumor growth and the inhibition of thymidylate synthetase in vivo].
    Nakamura H; Yu-Qin W; Miyauchi S; Nishioka N; Tanaka H; Harada N; Shirasaka T; Fujii S
    Gan To Kagaku Ryoho; 1984 May; 11(5):1049-55. PubMed ID: 6426401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidylate synthase inhibitors.
    Ismail AS; Grem JL
    Cancer Chemother Biol Response Modif; 2001; 19():1-19. PubMed ID: 11686010
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of thymidine kinase and thymidylate synthetase in the cytostatic, antimetabolic, and antitumor effects of the carbocyclic analogue of 5-nitro-2'-deoxyuridine. A comparison with 5-nitro-2'-deoxyuridine.
    Balzarini J; De Clercq E; Herdewijn P; Robins MJ
    Mol Pharmacol; 1985 May; 27(5):578-83. PubMed ID: 3990680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status.
    Papamichael D
    Oncologist; 1999; 4(6):478-87. PubMed ID: 10631692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and discovery of N-carbonylpyrrolidine- or N-sulfonylpyrrolidine-containing uracil derivatives as potent human deoxyuridine triphosphatase inhibitors.
    Miyakoshi H; Miyahara S; Yokogawa T; Chong KT; Taguchi J; Endoh K; Yano W; Wakasa T; Ueno H; Takao Y; Nomura M; Shuto S; Nagasawa H; Fukuoka M
    J Med Chem; 2012 Apr; 55(7):2960-9. PubMed ID: 22404301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a novel class of potent human deoxyuridine triphosphatase inhibitors remarkably enhancing the antitumor activity of thymidylate synthase inhibitors.
    Miyahara S; Miyakoshi H; Yokogawa T; Chong KT; Taguchi J; Muto T; Endoh K; Yano W; Wakasa T; Ueno H; Takao Y; Fujioka A; Hashimoto A; Itou K; Yamamura K; Nomura M; Nagasawa H; Shuto S; Fukuoka M
    J Med Chem; 2012 Apr; 55(7):2970-80. PubMed ID: 22339362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tumor growth and neovascularization by an anti-gastric ulcer agent, irsogladine.
    Ono M; Kawahara N; Goto D; Wakabayashi Y; Ushiro S; Yoshida S; Izumi H; Kuwano M; Sato Y
    Cancer Res; 1996 Apr; 56(7):1512-6. PubMed ID: 8603395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 6-azauridine on plasma cell tumors of mice: correlation of antitumor effect with inhibition of orotic acid metabolism.
    Conn HO; Creasey WA; Calabresi P
    Cancer Res; 1967 Apr; 27(4):618-25. PubMed ID: 6071670
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibition of thymidylate synthase in chemotherapy].
    Rode W
    Postepy Biochem; 1996; 42(2):133-40. PubMed ID: 8805186
    [No Abstract]   [Full Text] [Related]  

  • 12. Thymidylate synthase inhibitors.
    Takimoto CH; Diggikar S
    Cancer Chemother Biol Response Modif; 2005; 22():1-18. PubMed ID: 16110605
    [No Abstract]   [Full Text] [Related]  

  • 13. Thymidylate synthase inhibitors.
    Ackland SP; Clarke SJ; Beale P; Peters GJ
    Cancer Chemother Biol Response Modif; 2002; 20():1-36. PubMed ID: 12703198
    [No Abstract]   [Full Text] [Related]  

  • 14. Alkylating agents.
    Berger NA
    Cancer Chemother Biol Response Modif; 1994; 15():32-43. PubMed ID: 7779588
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of 5-fluorouracil derivative UFT on thymidylate synthetase and thymidine kinase in rat colorectal tumors.
    Sakamoto S; Kawachi Y; Iwama T; Kuwa K; Suzuki T; Mitamura T; Kudo H; Sassa S; Yoshimura S; Maemura T; Nakayama T; Ohsawa M; Hara Y
    Anticancer Res; 1999; 19(1A):245-50. PubMed ID: 10226549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and cytostatic properties of 5-substituted derivatives of 3-methylisoxazolo[5,4-d]1,2,3-triazine-4-ones and 3-methyl-5-triazene 4-isoxazolecarboxylic acid ethyl esters.
    Ryng S; Malinka W; Duś D
    Farmaco; 1997 Feb; 52(2):105-8. PubMed ID: 9181691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approaches for targeting thymidylate synthase to overcome the resistance and toxicity of anticancer drugs.
    Garg D; Henrich S; Salo-Ahen OM; Myllykallio H; Costi MP; Wade RC
    J Med Chem; 2010 Sep; 53(18):6539-49. PubMed ID: 20527892
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug concentration in cancerous large bowel tissue and thymidylate synthase inhibition rate after administration of tegafur and UFT].
    Futami K; Arima S; Yoshimura S; Okamoto T; Yamasaki K; Koto T; Yamasaki S; Kawahara K; Ikuno T
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):215-20. PubMed ID: 1992915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidylate synthase inhibitors in colorectal cancer.
    Cassidy J
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):83-7. PubMed ID: 11049037
    [No Abstract]   [Full Text] [Related]  

  • 20. The in vitro effect of the antineoplastic agent bryostatin 4 on human hematopoietic progenitor cells.
    Gebbia V; Di Marco P; Miceli S; Reyes MB; Teresi M; Bonaccorso R; Citarrella P; Rausa L
    Haematologica; 1988; 73(5):387-91. PubMed ID: 3143638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.